Eiger BioPharmaceuticals, Inc. (EIGR) Financial Statements (2023 and Earlier)

Company Profile

Business Address 2155 PARK BOULEVARD
PALO ALTO, CA 94306
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:88,800128,90095,000100,35341,77959,93632,777
Cash and cash equivalents22,22128,86439,37361,26232,03527,75632,777
Short-term investments66,59499,97655,62139,0919,74432,180 
Other undisclosed cash, cash equivalents, and short-term investments(15)606    
Receivables2,576     226
Inventory, net of allowances, customer advances and progress billings2,612      
Inventory2,612      
Prepaid expense631448    290
Other undisclosed current assets8,7458,4585,3841,492712581583
Total current assets:103,364137,806100,384101,84542,49160,51733,876
Noncurrent Assets
Operating lease, right-of-use asset6531,1761,654
Property, plant and equipment6137095901677976(13)
Long-term investments and receivables17,262      
Long-term investments17,262      
Other noncurrent assets4,5103,9032,51143631214310
Other undisclosed noncurrent assets      13
Total noncurrent assets:23,0385,7884,75560339121910
TOTAL ASSETS:126,402143,594105,139102,44842,88260,73633,886
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,46416,04516,41510,0245,2675,2881,108
Accounts payable7,7654,6406,4145,8303,1832,639479
Accrued liabilities13,69911,40510,0014,1942,0842,649577
Employee-related liabilities      52
Debt7,809 534 2,002  
Restructuring reserve      1,201
Other undisclosed current liabilities628582     
Total current liabilities:29,90116,62716,94910,0247,2695,2882,309
Noncurrent Liabilities
Long-term debt and lease obligation24,10231,93231,71025,62013,091  
Long-term debt, excluding current maturities23,98631,19430,39025,62013,091  
Operating lease, liability1167381,320
Liabilities, other than long-term debt, including:   212  24
Other liabilities   212   
Other undisclosed liabilities, other than long-term debt      24
Other undisclosed noncurrent liabilities(116)(738)   14,727 
Total noncurrent liabilities:24,10231,93231,71025,83213,09114,72724
Total liabilities:54,00348,55948,65935,85620,36020,0152,333
Stockholders' equity
Stockholders' equity attributable to parent72,39995,03556,48066,59222,52240,72131,553
Common stock353424191182
Additional paid in capital412,930401,509297,863237,795141,320117,086222,403
Accumulated other comprehensive income (loss)(149)(8)42(25)(3)(15) 
Accumulated deficit(340,417)(306,500)(241,449)(171,197)(118,806)(76,358)(190,852)
Total stockholders' equity:72,39995,03556,48066,59222,52240,72131,553
TOTAL LIABILITIES AND EQUITY:126,402143,594105,139102,44842,88260,73633,886

Income Statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues12,142      
Cost of revenue(745)      
Gross profit:11,397      
Operating expenses(88,336)(62,149)(68,904)(51,047)(41,520)(46,120)(42,181)
Operating loss:(76,939)(62,149)(68,904)(51,047)(41,520)(46,120)(42,181)
Nonoperating income (expense)46,6456922,058985596(277)70
Investment income, nonoperating1587042,073997410 65
Other nonoperating income (expense)46,487(12)(15)(12)186(277)5
Interest and debt expense(3,559)(3,594)(3,406)(2,329)(1,524)(690)(2,302)
Loss from continuing operations before income taxes:(33,853)(65,051)(70,252)(52,391)(42,448)(47,087)(44,413)
Income tax expense(64)      
Net loss available to common stockholders, diluted:(33,917)(65,051)(70,252)(52,391)(42,448)(47,087)(44,413)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(33,917)(65,051)(70,252)(52,391)(42,448)(47,087)(44,413)
Comprehensive loss:(33,917)(65,051)(70,252)(52,391)(42,448)(47,087)(44,413)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(141)(50)67(22)12(15)8
Comprehensive loss, net of tax, attributable to parent:(34,058)(65,101)(70,185)(52,413)(42,436)(47,102)(44,405)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: